Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-26-013913
Filing Date
2026-04-29
Accepted
2026-04-29 17:13:09
Documents
99
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nby20251231d_10ka.htm   iXBRL 10-K/A 2677522
2 EXHIBIT 23.3 ex_951019.htm EX-23.3 5702
3 EXHIBIT 23.4 ex_951020.htm EX-23.4 5388
4 EXHIBIT 31.3 ex_951021.htm EX-31.3 8376
5 EXHIBIT 31.4 ex_951022.htm EX-31.4 8527
6 EXHIBIT 32.3 ex_951023.htm EX-32.3 4439
7 EXHIBIT 32.4 ex_951024.htm EX-32.4 4111
  Complete submission text file 0001437749-26-013913.txt   15063888

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sdev-20251231.xsd EX-101.SCH 119876
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20251231_def.xml EX-101.DEF 894266
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20251231_lab.xml EX-101.LAB 630751
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20251231_pre.xml EX-101.PRE 934766
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdev-20251231_cal.xml EX-101.CAL 58594
103 EXTRACTED XBRL INSTANCE DOCUMENT nby20251231d_10ka_htm.xml XML 2996061
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33678 | Film No.: 26917984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)